Targeted Interleukin‐9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell study-Reference-Cited by-同舟云学术

Targeted Interleukin‐9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell study

Published:2022-11-26 Issue:3 Volume:53 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Heiss Judith¹²,Grün Katja¹,Tempel Laura¹,Matasci Mattia³^ORCID,Schrepper Andrea⁴,Schwarzer Michael⁴,Bauer Reinhard⁵,Förster Martin¹,Berndt Alexander⁶,Jung Christian⁷,Schulze P. Christian¹,Neri Dario³,Franz Marcus¹^ORCID

Affiliation:

1. Department of Internal Medicine I University Hospital Jena Jena Germany

2. Else Kröner Graduate School for Medical Students “JSAM” Jena University Hospital Jena Germany

3. Philochem AG Otelfingen Switzerland

4. Department of Cardiothoracic Surgery University Hospital Jena Jena Germany

5. Institute of Molecular Cell Biology, Center for Molecular Biomedicine University Hospital Jena Jena Germany

6. Section Pathology, Institute of Legal Medicine University Hospital Jena Jena Germany

7. Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty Heinrich‐Heine University Düsseldorf Düsseldorf Germany

Funder

Else Kröner-Fresenius-Stiftung

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13907

Reference50 articles.

1. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie N;Eur Heart J,2015

2. The pathogenesis of pulmonary hypertension: an update;Huber LC;Swiss Med Wkly,2015

3. The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension

4. Management of Pulmonary Arterial Hypertension

5. Current Insights on the Pathogenesis of Pulmonary Arterial Hypertension

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein isoform-centric therapeutics: expanding targets and increasing specificity;Nature Reviews Drug Discovery;2024-09-04

2. Extra domain A-containing fibronectin in pulmonary hypertension and treatment effects of a function-blocking antibody;Cardiovascular Research;2024-07-18

3. Biochemical and molecular determinants of the subclinical inflammatory mechanisms in Rett syndrome;Archives of Biochemistry and Biophysics;2024-07

4. Expression of Inflammatory Genes in Murine Lungs in a Model of Experimental Pulmonary Hypertension: Effects of an Antibody-Based Targeted Delivery of Interleukin-9;Advances in Respiratory Medicine;2024-01-03

5. Immunomodulatory macrophages and Treg in pulmonary hypertension;Comparative Clinical Pathology;2023-11-24